The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Completed
Major Depression
Bipolar I Disorder
Bipolar II Disorder
Unipolar Depression
Start Date: Jun 2017
Last Updated: Feb 2022
Baltimore, Maryland, USA
/
Cincinnati, Ohio, USA
/
Ann Arbor, Michigan, USA
and 1 more
Ketamine